Cambridge Acquisition Corp. (CAQ) company profile

The company is a blank check entity formed to carry out a merger, share exchange, asset acquisition, reorganization, or similar business combination with one or more operating enterprises. It currently does not offer commercial products or services, nor does it generate revenue from business segments. The entity has no active customers because its primary activity centers on sourcing, evaluating, and negotiating a potential business combination. Management targets businesses operating in high-growth, recession-resilient sectors such as nicotine harm reduction, functional botanicals, psychedelics, and wellness platforms.

The entity is organized as an exempted company in the Cayman Islands, and the provided text does not identify a separate headquarters location. It does not operate any physical facilities, branch offices, or retail locations. Geographically, the firm directs its primary acquisition search toward target businesses situated within the United States and Europe, although it retains the flexibility to pursue commercial opportunities across any industry and global region.

Summary of the business section of Cambridge Acquisition's latest annual report, written by StockData.

“Each unit has an offering price of $10.00 and will consist of one Class A ordinary share and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.